Why the study?
Does the implantable cardioverter-defibrillator prevent sudden death in patients with hypertrophic cardiomyopathy?
Does the implantable cardioverter-defibrillator prevent sudden death in patients with hypertrophic cardiomyopathy?
This paper discusses new perspectives on risk stratification and the use of implantable cardioverter-defibrillators for the prevention of sudden death in hypertrophic cardiomyopathy.
B.J. Maron; Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter–defibrillator
No takes yet. Share an insight, caveat, or question.
Barry J. Maron (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: